Team Novo Nordisk
|Status||UCI Professional Continental|
|Website||Team home page|
|General manager||Vassili Davidenko|
|Team name history|
|Team Type 1 (TT1)
Team Type 1-Sanofi Aventis (TT1)
Team Type 1-Sanofi (TT1)
Team Novo Nordisk (TNN)
Team Novo Nordisk is a global all-diabetes sports team of cyclists, triathletes and runners, spearheaded by the world’s first all-diabetes professional cycling team. The team’s mission is to inspire, educate and empower people affected by diabetes.
The team strives to instill hope and inspiration for people around the world affected by diabetes and believes with appropriate diet, exercise, treatment and technology, anyone with diabetes can pursue their dreams.
Pro Cycling Team
Team Novo Nordisk is the first professional cycling team to be comprised completely of riders living with type 1 diabetes. All riders, including Javier Megias, Andrea Peron and Martijn Verschoor, and several of the team’s staff, including Phil Southerland and VP of Marketing Matt Vogel, are living with diabetes.
In addition to the world’s first all-diabetes pro cycling team, Team Novo Nordisk is home to an elite program of world-class endurance athletes living with diabetes.
Women’s Team The Team Novo Nordisk Women’s Team includes an international mix of national, collegiate and USA Crit champions, Olympic hopefuls and riders of all levels competing in top criteriums, road and track events.
Mountain Bike/Cyclocross The Team Novo Nordisk Mountain Bike/Cyclocross Team competes in mountain bike events such as, downhill, cross country and endurance, as well as cyclocross events throughout the U.S. These inspiring men and women manage careers, families and diabetes, while achieving athletic feats to amaze and inspire.
Running/Triathlon Team Novo Nordisk runners include world-class Marathoners, Ultra runners and Olympic hopefuls. The triathletes compete in premier world events such as France’s Long Course World Championships and the Ironman World Championship in Kona.
Type 2 All members of the Team Novo Nordisk T2 Team are living with type 2 diabetes. The T2 athletes utilize cycling and running, along with proper diet and diabetes management, as a means of staying healthy and active. The athletes range in age from early 30’s to over 70, and they are eager to share their experiences to inspire everyone living with diabetes.
In 2013, Team Novo Nordisk became the first-ever professional cycling team to feature an all-diabetes roster. The team continued to race on the International Cycling Union (UCI) Professional Continental tour, and competed in major professional races, including the Presidential Cycling Tour of Turkey, Tour de Beauce, Post Danmark Rundt (Tour of Denmark) and USA Pro Cycling Challenge.
The team expanded for the 2011 season, its first as a Professional Continental team, 2013 List of UCI Professional Continental and Continental teams, with signings including former Tour de France yellow jersey-wearer Rubens Bertogliati and Russian Alexander Efimkin, who went on to win the Presidential Tour of Turkey in May. The team unsuccessfully sought a wildcard entry to the 2011 Giro d'Italia.
In 2012, Southerland and global healthcare company, Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. Today, Team Novo Nordisk competes on a global scale and its athletes are vehicles of empowerment for people with diabetes worldwide.
The team has competed in a number of major professional events, such as the Tour of California and the Tour de Langkawi and picked up two stage wins in the 2010 Tour du Maroc. In 2010, the team's calendar featured a number of international races, including the Tour de Bretagne Cycliste, the Tour de Taiwan, the Tour of Ireland and the Tour of Japan. The team's main goal for the 2010 season was the Tour of California, an eight-stage race held in May in which Thomas Rabou won the King of the Mountains competition.
In 2009, the team won the Race Across America, having entered a team of cyclists who all had type 1 diabetes. The team has also competed in a number of major professional events, such as the Tour of California and the Tour de Langkawi, and picked up two stage wins in the 2010 Tour du Maroc.
The team turned professional in 2008 after success in amateur races. In 2010 it had a UCI Continental licence but became a Professional Continental team in 2011, with a view to competing in the Giro d'Italia in 2011 and the Tour de France in 2012. The team had originally aimed to achieve the Professional Contintental level for the 2010 season but decided against applying for an upgraded licence because of fears that it might preclude the team from competing in events outside the responsibility of the International Cycling Union and a lack of knowledge by the team's management of the scale of investment that would be required to compete at the higher level.
In 2006, Phil Southerland and Joe Eldridge assembled a group of eight cyclists with type 1 diabetes to take on the grueling 3,000 mile Race Across America to raise diabetes awareness. The team went on to win the event in 2007, 2009 and 2010 and quickly became a magnet for endurance athletes with diabetes.
In 2005, Phil Southerland and Joe Eldridge founded the team, then known as Team Type 1, to provide inspiration for people living with diabetes and "an opportunity to compete at the sport's highest levels".
- As of February 2, 2014.
- 1st Stage 5 Tour de Taiwan, Shawn Milne
- 1st Stage 6 Tour de Beauce, Matthew Wilson
- 1st Overall Vuelta Mexico, Glen Chadwick
- 1st Stage 2 Fitchburg Longsjo Classic, Ian MacGregor
- 1st US Air Force Cycling Classic, Shawn Milne
- 1st Stage 1 Vuelta Mexico, Aldo Ino Ilešič
- 1st Overall Presidential Tour of Turkey, Alexander Efimkin
- 1st Stage 2 Tour de Beauce, Martijn Verschoor
- 1st Overall Tour of Rwanda, Kiel Reijnen
- 1st Stage 5 Tour de Korea, Alexander Serebryakov
- 1st Philadelphia International Championship, Alexander Serebryakov
- 1st Stage 5 Tour de Beauce, Vegard Stake Laengen
- 1st Stage 1 Tour of Austria, Alessandro Bazzana
- 1st Stage 8 Tour of Austria, Daniele Colli
- 1st Stage 7 Tour of Qinghai Lake, Aldo Ino Ilešič
- 1st Stages 1 & 3 Tour du Limousin, Jure Kocjan
- 1st Stage 4 Tour do Rio, Aldo Ino Ilešič
- 1st Stages 2 & 5 Tour of China I, Alexander Serebryakov
- 1st Stage 3 Tour of China I, Aldo Ino Ilešič
- 1st Stages 1 & 2 Tour of China II, Alexander Serebryakov
- 1st Stages 3, 4 & 9 Tour of Hainan, Alexander Serebryakov
- 1st Stages 3 & 5 Tour of Taihu Lake, Alexander Serebryakov
- "About Team Type 1". www.teamtype1.org. Retrieved 18 June 2012.
- Kirsten Frattini (February 18, 2010). "Team Type 1 jump starts season in Georgia". Cyclingnews.com (Future plc). Retrieved 2010-04-15.
- Ryan, Barry (14 September 2010). "Team Type 1 announce seven signings for 2011". Cycling News. Retrieved 18 June 2012.
- Hood, Andrew (1 May 2011). "Alexander Efimkin wins 2011 Presidential Cycling Tour of Turkey". Velonews. Retrieved 18 June 2012.
- Kirsten Frattini (February 19, 2010). "Professional Continental dream could become reality for Team Type 1". Cyclingnews.com (Future plc). Retrieved April 11, 2010.
- i. "Amgen Tour of California, California, United States, 2.HC". Cyclingnews.com (Future plc). Retrieved April 11, 2010.
- "Team Type 1 "fired up and ready to race"". Cyclingnews.com (Future plc). March 19, 2010. Retrieved 2010-04-15.
- Tara Parker-Pope (June 29, 2009). "A 3,000-Mile Triumph, Spurred on by Diabetes". New York Times. Retrieved April 10, 2009.
- "US outfit Team Type 1 depending on Aussie Wilson to deliver in LTdL". The Star. February 7, 2008. Retrieved April 10, 2009.
- "Team Type 1 riders are back!". Bike World News. February 7, 2008. Retrieved March 25, 2009.
- "Team Type 1 successful in Tour du Maroc". cyclingnews.com. April 3, 2010. Retrieved April 11, 2010.
- "Team Type 1 stays Continental, moves to Atlanta". Cyclingnews.com (Future plc). September 1, 2009. Retrieved April 11, 2010.
- "Team Novo Nordisk (TNN) - USA". UCI Continental Circuits. Union Cycliste Internationale. Retrieved February 2, 2014.